The method of embodiment 51, wherein the composition comprises between about 0.01% to about 20% by weight of the povidone, about 0.01% to about 15% by weight of the povidone, about 0.01% to about 10% by weight of the povidone, about 0.01% to about 7% by weight of the povidone, about 0.01% to about 5% by weight of the povidone, about 0.01% to about 3% by weight of the povidone, about 0.01% to about 2% by weight of the povidone, or about 0.01% to about 1% by weight of the povidone
as in the case of the elevated mRNA, the basal bioavailable selenium may become the limiting factor for the efficient translation, whereas in the case of the elevated bioavailable selenium, the basal mRNA levels of seleno-GPxs may become the limiting factor for the overall increase of the protein activity
One of the resultant proteins is localized to the mitochondria the other to the cytosol
Taken together, previous studies show that TMAO can aggravate the process of atherosclerotic plaques by promoting vascular calcification